Parent Intervention to Prevent Disordered Eating in Children With Type 1 Diabetes (PRIORITY)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04741568 |
|
Recruitment Status :
Recruiting
First Posted : February 5, 2021
Last Update Posted : August 18, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Diabetes Mellitus, Type 1 Disordered Eating Children, Only Eating Disorders Parents | Behavioral: Parental psychoeducational Intervention | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 70 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Development and Feasibility of a Parent Intervention to Prevent Disordered Eating in Children and Young People With Type 1 Diabetes |
| Actual Study Start Date : | June 7, 2021 |
| Estimated Primary Completion Date : | May 1, 2022 |
| Estimated Study Completion Date : | November 22, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Parental Psychoeducational Intervention
A brief (one-day or two half days) psychoeducation workshop will be provided alongside a website with downloadable content will be made available to review and refresh any skills and techniques. The psychoeducational intervention will be delivered by a research fellow and research assistant with a background in psychology and delivered in line with a protocol.
|
Behavioral: Parental psychoeducational Intervention
The psychoeducation intervention for parents will focus on providing skills, knowledge and support motivation for caregivers of children with diabetes. A brief (one-day or two half days) workshop, and a website with downloadable content will be made available to review and refresh any skills and techniques. |
|
No Intervention: Wait List Control
Parents randomised to the control arm will be put on the waiting list (wait-list controls) to receive the group intervention after the active treatment group have completed their final follow-up at 3 months.
|
- Change in Diabetes Eating Problem Survey Revised (Markowitz et al., 2010) [ Time Frame: Baseline, 1-month and 3-months ]A child and parent reported survey of eating problems. Responses are scored on a 6-point Likert scale and higher scores indicate greater eating disorder pathology.
- Change in child HbA1c [ Time Frame: Baseline, 1-month and 3-months ]Parent reported HbA1c of children
- Change in Body Mass Index (weight and height will be combined to report BMI in kg/m^2) [ Time Frame: Baseline, 1-month and 3-months ]Parent reported weight and height of children used to calculate BMI
- Change in Problem Areas in Diabetes Survey Parent Revised (Markowitz et al., 2012) [ Time Frame: Baseline, 1-month and 3-months ]A parent-reported survey to assess diabetes related distress, higher scores indicate greater diabetes distress.
- Change in Warwick Edinburgh Mental Wellbeing Scale (Tennant et al., 2007) [ Time Frame: Baseline, 1-month and 3-months ]A self report survey to assess parental mental wellbeing. Scores range from 14 to 70 and higher scores indicate greater positive mental wellbeing.
- Change in Psychological Determinants [ Time Frame: Baseline, 1-month and 3-months ]Information Motivation Behvaioural Skills model questionnaire devised for this study completed by parents
- Intervention Feedback Survey [ Time Frame: 3 months ]Satisfaction and experience with intervention survey devised for this study
- Change in Children's Eating Behaviour Questionnaire (Wardle et al. 2001) [ Time Frame: Baseline, 1-month and 3-months ]A parent rated instrument to assess eight dimensions of eating style in children. Includes 35 items rates on a 5-point scale, higher scores indicate greater child behaviour for each dimension (e.g. emotional overeating, enjoyment of food).
- Demographics [ Time Frame: Baseline ]Parent completed T1D clinical characteristics and healthcare utilisation survey devised for this study (child age, gender, years with diagnosis, number of hospital visits in the last year)
- Feasibility Outcomes: Number of Participants Invited to the Study [ Time Frame: 3 months ]Number of parents invited to the study
- Feasibility Outcomes: Number of Participants Interested in Participating in the Study [ Time Frame: 3 months ]Number of Participants Interested in Participating in the Study
- Feasibility Outcomes: Number of parents meeting eligibility criteria [ Time Frame: 3 months ]Number of parents meeting eligibility criteria
- Feasibility Outcomes: Number of parents recruited and participating in the intervention [ Time Frame: 3 months ]Number of parents recruited and participate in the intervention
- Feasibility Outcomes: Completion Rates (will be calculated from number of parents recruited, number of parents completing the intervention) [ Time Frame: 3 months ]We look at the number of enrolled parents who have completed the intervention divided by the total number of parents who have completed the intervention or withdrawn or cancelled.
- Feasibility Outcomes: Retention Rates (will be calculated from number of parents recruited and participating in the intervention) [ Time Frame: 3 months ]The total number of parents students (including any who have withdrawn), minus the number of parents who have withdrawn or cancelled their enrollment, and divide this by the total number of enrolled parents.
- Feasibility Outcomes: Usability of Online Content (Google Analytics) [ Time Frame: 3 months ]Analysis on usability of online content. Data obtained from Google Analytics (e.g. website traffic, session duration, pages per session)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Parent or primary caregiver of a CYP aged between 11-14 years with a diagnosis of T1D
- Willing to attend group intervention and provide consent
- Fluent in English or Welsh
Exclusion Criteria:
- Parent receiving psychological support for their child's diabetes and disordered eating
- Parent diagnosis of severe mental health or learning difficulty
- Participating in another trial
- Unable to speak or understand English or Welsh
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04741568
| Contact: Rose-Marie Satherley, PhD | +44 01483 684518 | r.satherley@surrey.ac.uk | |
| Contact: Nicola Vince, BSc | +44 01483 684518 | n.vince@surrey.ac.uk |
| United Kingdom | |
| Royal Alexandra Children's Hospital | Recruiting |
| Brighton, United Kingdom | |
| Contact: Shankar Kanumakala | |
| Royal Surrey Hospital | Recruiting |
| Guildford, United Kingdom | |
| Contact: Debbie Evans | |
| Betsi Cadwaladr University Health Board | Recruiting |
| Holywell, United Kingdom | |
| Contact: Rose Stewart | |
| Principal Investigator: | Christina Jones, PhD | University of Surrey |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | University of Surrey |
| ClinicalTrials.gov Identifier: | NCT04741568 |
| Other Study ID Numbers: |
SPON/2020/07/FHMS 19/0006123 ( Other Grant/Funding Number: DiabetesUK ) |
| First Posted: | February 5, 2021 Key Record Dates |
| Last Update Posted: | August 18, 2021 |
| Last Verified: | August 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Diabetes Mellitus Diabetes Mellitus, Type 1 Feeding and Eating Disorders Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Autoimmune Diseases Immune System Diseases Mental Disorders |

